CLINICAL TRIALS PROFILE FOR VYZULTA
✉ Email this page to a colleague
All Clinical Trials for VYZULTA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03931317 ↗ | Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity | Completed | Bausch & Lomb Incorporated | N/A | 2018-12-03 | The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye. |
NCT03931317 ↗ | Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity | Completed | University of California, San Diego | N/A | 2018-12-03 | The purpose of this research study is to compare the effect of Latanoprostene Bunod and Timolol on eye pressure and blood vessels of the back of the eye. |
NCT03949244 ↗ | Nailfold Capillary Blood Flow With Latanoprost Bunod | Completed | Icahn School of Medicine at Mount Sinai | Phase 4 | 2019-08-15 | The purpose of this study is to look at the relationship of small blood vessels irregularities observed with an imaging system called video nailfold capillaroscopy in people with primary open-angle glaucoma. Nailfold capillaroscopy (NFC) is a video camera with a magnifying lens used for studying the movement of blood in small blood vessels. It is simple, safe and does not penetrate the skin. The skin fold that is at the tip of the finger is called the "nailfold". NFC has been used to assess blood vessel narrowing in patients with glaucoma. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VYZULTA
Condition Name
Clinical Trial Locations for VYZULTA
Trials by Country
Clinical Trial Progress for VYZULTA
Clinical Trial Phase
Clinical Trial Sponsors for VYZULTA
Sponsor Name